Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)

China · Delayed Price · Currency is CNY

64.39

-2.12 (-3.19%)

Feb 13, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Chemical Preparations	1.08B
Chemical Preparations Growth	22.25%
Application Programming Interface	121.14M
Application Programming Interface Growth	28.65%
Contract Manufacturing Organization/Contract Development and Manufacturing Organization	65.20M
Contract Manufacturing Organization/Contract Development and Manufacturing Organization Growth	111.59%
Technical Services and Transfer	62.90M
Technical Services and Transfer Growth	-42.81%
Other	23.81M
Other Growth	1572.51%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	1.32B
China Growth	20.04%
Overseas	25.26M
Overseas Growth	84.41%